This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vivreon Biosciences, LLC. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Clayton A White: Innovator in CRAC Channel Modulation
Introduction
Clayton A White is a notable inventor based in Costa Mesa, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of CRAC channels. His innovative work has led to the development of compounds that have the potential to treat various conditions associated with CRAC channel activity.
Latest Patents
Clayton A White holds 1 patent. His patent describes compounds that modulate the activity of CRAC channels, methods of making such compounds, pharmaceutical compositions, and medicaments containing such compounds. Additionally, it outlines methods for using these compounds in the treatment of conditions, diseases, or disorders linked to CRAC channel activity.
Career Highlights
Clayton is currently associated with Vivreon Biosciences, LLC, where he continues to advance his research and development efforts. His work at Vivreon has positioned him as a key player in the biotechnology sector, focusing on innovative solutions for health-related challenges.
Collaborations
Clayton has collaborated with notable professionals in his field, including Milton L Greenberg and John Ransom. These collaborations have further enriched his research and contributed to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Clayton A White's contributions to the modulation of CRAC channels exemplify the impact of innovative thinking in the pharmaceutical industry. His work not only highlights his expertise but also underscores the importance of collaboration in driving scientific advancements.